Reuters logo
BRIEF-Dynavax Technologies receives notification of PDUFA extension for Heplisav-B
2016年4月27日 / 中午11点32分 / 2 年前

BRIEF-Dynavax Technologies receives notification of PDUFA extension for Heplisav-B

April 27 (Reuters) - Dynavax Technologies Corp

* Says Dynavax receives notification of PDUFA extension for Heplisav-B to Dec. 15, 2016

* Says U.S. FDA will require additional time to complete its review of biologics license application for Heplisav-B Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below